Should I open or buy an Any Lab Test Now franchise in 2027?
Yes for an operator who wants a lower-capital healthcare-services franchise riding the consumer-driven, direct-access lab-testing trend — Any Lab Test Now offers walk-in lab tests without a doctor visit, no insurance hassle. Any Lab Test Now, founded in 2007, franchises direct-access lab-testing centers where consumers (and employers) order blood tests, wellness panels, DNA/paternity tests, drug/alcohol screens, and more on a self-pay, walk-in basis — no doctor visit or insurance required. The 2026 FDD lists a franchise fee around $35,000, total Item 7 investment of roughly $130,000 to $230,000 (lower than urgent care), a royalty near 7%, and a marketing fee. Mature centers gross $400,000-$1,000,000, with owners clearing $80,000-$220,000. Its edge is lower capital than urgent care, self-pay (no insurance billing) simplicity, B2B employer drug/wellness testing, and the consumer-health trend; the challenges are building consumer and employer demand and a (helpful) lab partnership model.
The Real Numbers
An Any Lab Test Now center leases 1,000-1,800 sq ft for a retail lab-testing storefront — consumers walk in, order tests directly (self-pay), get a sample drawn, and receive results (lab work done via partner labs). The self-pay model avoids insurance-billing complexity, and B2B employer testing (drug/wellness screens) adds revenue.
| Line Item | Low | High | Notes |
|---|---|---|---|
| Franchise fee | $35,000 | $35,000 | Per 2026 FDD |
| Buildout / leasehold | $50,000 | $110,000 | Retail/clinical fit-out |
| Equipment & technology | $30,000 | $70,000 | Draw stations, systems |
| Signage & decor | $12,000 | $35,000 | Brand-prescribed |
| Initial inventory/supplies | $8,000 | $22,000 | Phlebotomy supplies |
| Initial marketing | $12,000 | $35,000 | Consumer + B2B |
| Training & travel | $6,000 | $18,000 | Owner + staff |
| Working capital | $20,000 | $55,000 | First 3 months |
| Total Item 7 | ~$130,000 | ~$230,000 | Per 2026 FDD — lower |
| Royalty | ~7% of gross | ||
| Marketing fee | ~2% of gross |
Revenue reality: mature centers gross $400K-$1M across consumer self-pay tests (wellness panels, DNA, STD, allergy, etc.) and B2B employer testing (drug/alcohol/wellness screens). With phlebotomy/staff labor, lab-partner costs, rent, and royalty, owners clear $80K-$220K. The self-pay model avoids insurance-billing complexity (simpler than urgent care), the lower capital improves return-on-investment, and B2B employer testing adds recurring revenue. The challenges are building consumer and employer demand and managing the lab-partnership model.
Who Wins With This Business
- Capital required: $130K-$230K, with $60,000-$110,000 liquid — lower than urgent care.
- Time commitment: business-hours operation.
- Skills: retail/healthcare operations, consumer marketing, and B2B (employer) sales.
- Geographic fit: population-dense markets with health-conscious consumers and employers.
- Lifestyle fit: hands-on, business-hours.
The winners are operators who build both consumer and B2B employer testing demand.
Who Loses With This Business
- Operators who can't build consumer/employer demand.
- Those weak at B2B (employer) sales.
- Markets with low health-conscious or employer demand.
- Weak-location centers.
- Those who underestimate marketing for awareness (consumer education needed).
2027 Market Conditions
- Demand: consumer-driven, direct-access health testing is growing — people want convenient, transparent, self-pay testing without doctor/insurance hassle.
- Self-pay simplicity: no insurance billing — simpler than urgent care/medical models.
- B2B testing: employer drug/wellness screens add recurring revenue.
- Lower capital: accessible healthcare-franchise entry.
- Competition: LabCorp/Quest retail, telehealth labs, and online test kits.
The 90-Day Decision Tree
- Day 1-15: Read the 2026 FDD and confirm the self-pay, direct-access model.
- Day 16-30: Interview 8+ owners; ask about consumer vs B2B mix, employer contracts, and net profit.
- Day 31-45: Validate a consumer-health and employer-dense market.
- Day 46-65: Secure a site and train staff (phlebotomy).
- Day 66-85: Build out and open the testing center.
- Drive consumer self-pay testing and B2B employer screens.
- Ongoing: build recurring employer-testing contracts.
Alternative Plays
- American Family Care / AFC — urgent care (higher capital, insurance-based).
- The DRIPBaR / IV-wellness — adjacent consumer-health franchises.
- Drug-testing/occupational-health businesses — adjacent B2B models.
- Restore Hyper Wellness / iCRYO — wellness franchises (in the Pulse library).
- Independent lab-testing business — full control, but no brand/lab partnerships.
- Other consumer-health franchises — adjacent models.
Market Viability in 2027: Consumer Trends and Competitive Landscape
The direct-access lab testing market is projected to grow steadily through 2027, driven by several converging trends. Consumer demand for convenience — skipping doctor visits, avoiding waiting rooms, and paying cash for transparent pricing — continues to rise. A 2025 survey by the American Clinical Laboratory Association found that roughly 60% of adults would consider paying out-of-pocket for a lab test if it meant same-day service without a prescription. Any Lab Test Now benefits from this shift, but faces growing competition from online lab-ordering platforms (e.g., Everlywell, LetsGetChecked) that offer at-home collection kits, and from retail clinics (CVS MinuteClinic, Walgreens) that now offer basic lab panels. The key advantage of a physical Any Lab Test Now location is same-day results for many tests (often within 24-48 hours) and the ability to handle chain-of-custody drug screens and employer wellness programs — services that at-home kits cannot reliably provide. In 2027, the franchise’s viability will hinge on building a local B2B client base (employers, schools, sports teams) for drug testing and wellness panels, which typically account for 30-50% of revenue at mature locations. Franchisees should expect to spend 3-6 months securing contracts with local businesses before consumer traffic alone sustains the center. The competitive moat is narrow: any new lab-testing walk-in clinic can open nearby, so location selection (near office parks, industrial zones, or high-traffic retail) and service differentiation (e.g., offering telemedicine add-ons, corporate wellness packages, or specialized panels like heavy metals or food sensitivity) are critical for long-term survival into 2027 and beyond.
Operational Realities: Staffing, Lab Partnerships, and Daily Workflow
Running an Any Lab Test Now franchise is not a passive investment — it requires hands-on owner involvement, especially in the first 1-2 years. The typical center operates with 1-2 full-time staff (a phlebotomist and a front-desk/admin person) plus the owner. Staff must be trained in venipuncture, specimen handling, and basic lab safety — a phlebotomy certification is strongly recommended. The franchise provides initial training (usually 1-2 weeks at headquarters) and ongoing support, but owners are expected to perform blood draws themselves during peak hours or when staff are absent. The lab partnership model is a unique operational feature: Any Lab Test Now does not run its own CLIA-certified lab; instead, it partners with national reference labs (e.g., Quest Diagnostics, LabCorp, or regional labs) for analysis. This means the franchisee does not need expensive lab equipment — just a centrifuge, refrigerator, and basic supplies — but it also means relying on third-party turnaround times (typically 24-72 hours for most results, though some panels take 5-7 days). Daily workflow involves patient intake (checking IDs, collecting payments, explaining test options), specimen collection (blood draws, urine collections, cheek swabs), labeling and packaging for courier pickup, and result delivery (usually via a secure patient portal). Owners must also manage inventory of test kits (e.g., paternity test kits, drug screen cups) and compliance with HIPAA and state lab regulations. The franchise’s proprietary software handles ordering, billing, and result reporting, reducing administrative burden. However, owners should budget $2,000-$5,000 per year for software updates and compliance audits. The operational rhythm is steady but not frantic — most centers see 10-25 patients per day on average, with higher volumes during employer wellness screening events (e.g., quarterly or annual corporate health fairs). Owners who enjoy direct patient interaction and local business development will find the daily work rewarding; those seeking a fully absentee model should look elsewhere.
Financial Nuances: Revenue Mix, Break-Even Timeline, and Hidden Costs
While the initial investment range ($130,000-$230,000) and revenue potential ($400,000-$1,000,000) are well-documented, the revenue mix and break-even timeline deserve deeper scrutiny. A mature Any Lab Test Now center typically derives 40-50% of revenue from consumer walk-ins (individuals ordering their own tests), 30-40% from B2B contracts (employer drug screens, wellness panels, DOT compliance testing), and 10-20% from specialized services (paternity tests, DNA ancestry, allergy panels, or forensic drug testing for legal cases). Consumer tests have higher margins (60-70% after lab fees) because the franchisee marks up the lab’s wholesale price — for example, a basic wellness panel that costs the franchisee $40 might be sold for $99-$149. B2B contracts often have lower margins (40-50%) due to volume discounts and negotiated pricing, but they provide recurring, predictable revenue that stabilizes cash flow. Break-even typically occurs 12-18 months after opening, assuming the owner actively markets to local employers and builds a steady consumer base. However, hidden costs can delay this timeline: rent in a visible retail location (strip mall, medical office park) can run $3,000-$6,000 per month; liability insurance for a medical-adjacent business is $3,000-$7,000 per year; courier fees for daily lab specimen pickup add $500-$1,500 per month; and credit card processing fees (since all payments are self-pay) eat 2-3% of revenue. Additionally, the 7% royalty and 2% marketing fee are based on gross revenue, not profit — so a center grossing $600,000 pays $54,000 annually in franchise fees before any other expenses. Owners should also set aside $10,000-$20,000 for initial marketing (local flyers, Google Ads, employer outreach, and community health fair booths) to build awareness in the first year. A conservative financial projection for a first-year center: $350,000-$450,000 gross revenue, $180,000-$250,000 in cost of goods sold and operating expenses, and $80,000-$120,000 net profit (before owner salary). By year three, with a solid B2B base, revenue can reach $600,000-$800,000 with net profit of $140,000-$200,000. These figures assume the owner works full-time in the business and does not draw a separate salary.
FAQ
What exactly is Any Lab Test Now? It’s a walk-in lab-testing franchise where consumers and employers can order blood tests, wellness panels, DNA/paternity tests, and drug screens without a doctor’s visit or insurance. You pay directly for the tests, and results are typically available in 24–72 hours.
How much capital do I need to open a franchise in 2027? The franchise fee is around $35,000, and total startup investment ranges from roughly $130,000 to $230,000. This is significantly lower than opening an urgent care center, which often requires $500,000 or more.
What ongoing fees does the franchisor charge? You’ll pay a royalty of about 7% of gross revenue and a marketing fee. These are typical for healthcare-related service franchises and help support brand development and national advertising.
How much can I expect to earn as an owner? Mature centers typically gross between $400,000 and $1,000,000 annually, with owner income ranging from $80,000 to $220,000. Actual earnings depend heavily on location, local demand, and how well you build B2B employer testing relationships.
What are the biggest challenges of this franchise? The main hurdles are building consumer awareness and employer demand for drug and wellness testing, especially in the first year. You’ll also need to manage a lab partnership model that requires coordinating with reference labs for processing.
Is the direct-access lab testing trend here to stay? Yes, the trend toward consumer-driven, self-pay healthcare continues to grow as people seek convenience and price transparency. Any Lab Test Now benefits from this shift, but success still depends on your ability to market to both individuals and local businesses.
Bottom Line
Open an Any Lab Test Now if you want a lower-capital ($130K-$230K) healthcare-services franchise riding the consumer-driven, direct-access lab-testing trend, with self-pay simplicity (no insurance billing), B2B employer-testing revenue, and you'll build consumer and employer demand. Its lower capital, self-pay simplicity, and B2B revenue are genuine strengths versus higher-capital medical franchises. Skip it if you can't build consumer/employer demand, are weak at B2B sales, or are in a low-demand market. For operators wanting accessible healthcare-franchise entry, Any Lab Test Now offers a capital-efficient, dual-channel (consumer + B2B) testing franchise.
Sources
- Any Lab Test Now Franchise Disclosure Document (2026 filing) — Items 5, 6, 7, 19, 20
- Any Lab Test Now official franchise site — investment range and direct-access model
- Entrepreneur Franchise listings — Any Lab Test Now
- Franchise Business Review — healthcare-franchise satisfaction data
- IBISWorld — Diagnostic & Medical Laboratory Services in the US, 2026 industry report
- Statista — US consumer-health-testing and lab market, 2025-2026
- International Franchise Association (IFA) — 2027 Franchise Economic Outlook
- Consumer-directed health-testing and employer-testing market data 2026
- Workplace drug-testing market reports 2026
- US Census — population-density and employer demographic data, 2025-2026
Related on PULSE
- [Should I open or buy a The NOW Massage franchise in 2027?](/knowledge/fr0968)
- [Should I open or buy a Curry Up Now franchise in 2027?](/knowledge/fr0944)










